IMCR- Immunocore Holdings Plc
Immunocore Holdings Plc (IMCR) has 7 insiders with recent SEC Form 4 filings, including 4 buys and 24 sells. IMCR is classified in the Biotechnology industry within the Health Care sector.
Insider Ownership
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| Dir | 27.5K | $915.2K | - | |
| Dir | 27.5K | $915.2K | - | |
| Dir | 27.5K | $915.2K | - | |
| Dir | 27.5K | $915.2K | - | |
| Dir | 27.5K | $915.2K | - |
Activity
Buys and sells only
Transactions
10 filings
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec 5, 2025 | Berman David M85 | Head Of R&D | Sale+OE | 31,913 | $40.26 | $1,284,748.74 | -100% | -17.7% | - | |
| Nov 28, 2025 | Berman David M85 | Head Of R&D | Sale+OE | 74,925 | $40.12 | $3,005,825.37 | -100% | -18.8% | - | |
| Nov 25, 2025 | Berman David M85 | Head Of R&D | Sale+OE | 18,120 | $40.03 | $725,340.60 | -100% | -17.5% | - | |
| Sep 30, 2025 | Berman David M85 | Head Of R&D | Sale+OE | 61,849 | $35.23 | $2,178,940.27 | -100% | -2.7% | - | |
| Sep 15, 2025 | Berman David M85 | Head Of R&D | Sale+OE | 22,732 | $35.66 | $810,701.16 | -94.6% | +4.6% | - | |
| Sep 11, 2025 | Berman David M85 | Head Of R&D | Sale+OE | 50,419 | $36.20 | $1,824,967.24 | -97.7% | -1.5% | - | |
| Mar 17, 2025 | Baker Bros. Advisors LP59 | Director | Buy | 807,338 | $29.72 | $23,993,223.80 | +21.6% | +9.6% | +2.3% | |
| Apr 1, 2024 | St Leger Tina Amber | Chief Hr Officer | Sale+OE | 4,375 | $64.06 | $280,262.50 | -100% | -42.1% | -54.5% | |
| Feb 28, 2024 | Berman David M85 | Head Of R&D | Sale+OE | 36,509 | $68.59 | $2,504,158.49 | -52.6% | -33.1% | -57.3% | |
| Feb 27, 2024 | Berman David M85 | Head Of R&D | Sale+OE | 83,491 | $70.79 | $5,910,317.77 | -49.5% | -34.3% | -56.3% |
Page 1Next →